Answer within 24 Hours
Cylance is the first company to apply artificial intelligence (AI), algorithmic science and machine learning to cybersecurity. Using a breakthrough predictive analysis process, Cylance quickly and accurately identifies what is safe and what is a threat.
Cylance replaced legacy antivirus software with predictive, preventative solutions and services that protect the endpoint and the organization. Cylance takes a non-signature, non-heuristic approach to malware detection.
Cylance is a good choice for an organization of any size looking to augment or replace existing antivirus solutions.
Gartner 2017 Magic Quadrant for Endpoint Protection
Discover what makes Cylance machine learning stand out from the rest.
Read Data Sheet
See how Cylance's Artificial Intelligence provides real threat prevention and a 99.99% effectiveness rate.
Stop merely detecting attacks. Prevent them using CylancePROTECT, the only enterprise endpoint solution that blocks threats in real time BEFORE they ever cause harm.
See CylancePROTECT in action against the files associated with the highly publicized AGL energy phishing attacks.
CylancePROTECT is a next-neneration antivirus product that leverages artificial intelligence to detect AND prevent malware from executing on your endpoints in real time. See how it can protect your endpoints.
Discover how Cylance bolsters endpoint protection without PC performance impact or incremental costs.
ThreatZERO services expedite the implementation of CylancePROTECT, mitigate any risks that are identified, and facilitate immediate ROI, bringing clients to a state of PREVENTION.
ThreatZERO Services expedite the implementation of CylancePROTECT, mitigate any risks that are identified, and facilitate immediate ROI, bringing clients to a state of PREVENTION.
Cylance commissioned Forrester Consulting to conduct a Total Economic Impact™ (TEI) study and examine the potential 251% return on investment (ROI) enterprises may realize by deploying its advanced threat protection solution, CylancePROTECT.